| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |